Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms (MPNPH)

Odense University Hospital

Status: Completed

Conditions: Myeloproliferative Disorders; Pulmonary Hypertension

Treatments: Radiation: Radiology

Study type: Observational

Funder types: Other

Identifiers

NCT02580903

MPNPH

Details and patient eligibility

About

This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis.

All patients attending our department with the above mentioned neoplasms will be offered inclusion in this study. All will have an echo performed and patients identified as being at risk of pulmonary hypertension will be offered complete investigation as specified by the European Cardiology Association.

All patients will be followed up for a total of five years to identify prognosis.

Enrollment: 180 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Myeloproliferative Neoplasms (PV, ET, PMF according to WHO classification)

Exclusion criteria

• Pregnancy
• Lack of informed consent
• Age < 18 years
• Cognitive dysfunctions